A team of researchers co-led by TGen, part of City of Hope, have uncovered important molecular signatures that could help predict the progression of hepatic steatosis, a liver condition linked to obesity and other metabolic disorders.
Read ArticleTGen announced the appointment of John Fryer, Ph.D., as a professor in the Division of Bioinnovation and Genome Sciences and director of the newly established Center for Accelerated Nanotherapeutics. The appointment further advances TGen’s mission to accelerate leading-edge research in the fight against Alzheimer’s and other devastating diseases.
Read ArticleGlyphosate exposure linked to Alzheimer’s disease-like pathology in pre-clinical models
Read ArticleNicholas Banovich, Ph.D., associate professor and division director of Bioinnovation and Genome Sciences at TGen, part of City of Hope, will lead or co-lead three collaborative grants totaling over $22 million, with $8.2 million supporting research at TGen.
Read ArticlePHOENIX, Ariz. — Oct. 29, 2024 — TGen, part of City of Hope, and its partners in the Longevity Consortium have received a five-year, $45 million grant to move the consortium’s work to its next stage: integrating results from numerous studies about the factors that contribute to longer and healthier lives.
Read ArticleTogether, City of Hope Phoenix and TGen are accelerating the development of precision medicine enabled by advanced genomics, and working to bring those advances to more patients faster than ever before. This work will not only deliver tremendous benefits to Arizona and its people, but also patients all across the United States through City of Hope's national footprint of cancer centers.